Cleared Traditional

K932242 - RADIOACTIVE SAMARIUM 145 SEEDS/SOURCES #2341-2345
(FDA 510(k) Clearance)

Jul 1993
Decision
81d
Days
Class 2
Risk

K932242 is an FDA 510(k) clearance for the RADIOACTIVE SAMARIUM 145 SEEDS/SOURCES #2341-2345. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).

Submitted by Best Industries (Springfield, US). The FDA issued a Cleared decision on July 27, 1993, 81 days after receiving the submission on May 7, 1993.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K932242 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 1993
Decision Date July 27, 1993
Days to Decision 81 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement

Device Classification

Product Code KXK — Source, Brachytherapy, Radionuclide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5730

Similar Devices — KXK Source, Brachytherapy, Radionuclide

All 150
OncoPatch
K252296 · Oncopatch, Inc. · Dec 2025
IsoSphere
K242818 · Isoaid, LLC · Jul 2025
RadianceTx Radionuclide Brachytherapy Source
K223465 · Radiance Therapeutics, Inc. · Jan 2023
GammaTile
K221539 · Gt Medical Technologies · Nov 2022
Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles
K202267 · Isoray Medical, Inc. · Dec 2020
LV Liberty Vision Model 1 90Yttrium Brachytherapy Source
K193602 · Lv Liberty Vision Corporation · May 2020